Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Pharmaceutical API Manufacturing Market Report 2024

Pharmaceutical API Manufacturing Global Market Report 2024 – By Therapy Area (Cardiovascular Disorders, Metabolic Disorders, Neurological Disorders, Oncology, Musculoskeletal Disorders, Other Therapeutics Uses), By API Type (Chemical API, Biological API), By Drug Type (Prescription Drugs, Over-The-Counter (OTC) Drugs) – Market Size, Trends, And Global Forecast 2024-2033

Pharmaceutical API Manufacturing Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 250 | Published : March 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Pharmaceutical API Manufacturing Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Pharmaceutical API Manufacturing Market Definition

Pharmaceutical active pharmaceutical ingredients (API) manufacturing refers to the production of the active substances that give a pharmaceutical medicine its desired impact on the body to treat a condition. Chemical components must be processed in order to make APIs. A biological drug's active component is referred to as a bulk process intermediate.

The main therapy areas of pharmaceutical API manufacturing are cardiovascular disorders, metabolic disorders, neurological disorders, oncology, musculoskeletal disorders, NSAIDs, and other therapeutic uses. Cardiovascular diseases are a group of heart and blood vessel disorders. The various API types include chemical API and biological API which are used to produce innovative drugs, generic prescription drugs, and over-the-counter (OTC) drugs.

Pharmaceutical API Manufacturing Market Segmentation

The pharmaceutical api manufacturing market covered in this report is segmented –

1) By Therapy Area: Cardiovascular Disorders, Metabolic Disorders, Neurological Disorders, Oncology, Musculoskeletal Disorders, Other Therapeutics Uses

2) By API Type: Chemical API, Biological API

3) By Drug Type: Prescription Drugs, Over-The-Counter (OTC) Drugs

Global Pharmaceutical API Manufacturing Market Size 2023 to 2028: Graph

Pharmaceutical API Manufacturing Market Size 2024 And Growth Rate

The pharmaceutical api manufacturing market size has grown strongly in recent years. It will grow from $206.95 billion in 2023 to $219.76 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to increase in pharmaceutical r&d expenditure, increasing preference for outsourcing apis, growing prevalence of chronic illness, increased healthcare expenditure, a rise in disposable income, an increase in patent expiration and growing government policies for api production..

Pharmaceutical API Manufacturing Market Growth Forecast

The pharmaceutical api manufacturing market size is expected to see strong growth in the next few years. It will grow to $279.03 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to a rise in ageing population, rapid technological advancements, rising prevalence of cancer, increasing mergers and acquisitions and high potential of emerging economies will drive the growth.. Major trends in the forecast period include focus on production facility expansion, use of artificial intelligence (ai), focus on greener api manufacturing, increasing investments and focus on use of qr code labelling..

Book your 30 minutes free consultation with our research experts

Contact Us

Pharmaceutical API Manufacturing Market Driver: Rising Aging Population Fueling Growth In Pharmaceutical Api Manufacturing

The rise in the aging population is one of the major drivers of the pharmaceutical API manufacturing market. As the aging population increases, the demand for pharmaceutical drugs also increases. API acts as a specialty drug in these medicines to cure a particular disease. For instance, in October 2022, according to an article shared by WHO, a Switzerland-based specialized agency of the United Nations responsible for international public health, 80% of senior citizens will reside in low- and middle-income nations by 2050. The population is aging considerably more quickly than in the past. In 2020, there will be more persons over the age of 60 than under five-year-olds. Therefore, the rise in the aging population is driving the growth of the pharmaceutical API manufacturing market.

Pharmaceutical API Manufacturing Market Driver: Rise In Chronic Conditions Are Anticipated To Fuel The Growth Of The Pharmaceutical Api Manufacturing Market

The rise in chronic conditions is expected to propel the pharmaceutical API manufacturing market going forward. Chronic conditions, also known as chronic diseases, refer to long-term health conditions that last for extended periods, often for a person's entire life, and typically cannot be cured completely. The quality, effectiveness, and safety of the medication depend largely on the API used. Pharmaceutical API manufacturing helps to produce essential medications for managing chronic diseases. or instance, in 2023, according to the National Library of Medicine, a US-based government medical library, by 2035, nearly 36% of US adults aged 50 and older are projected to have at least one chronic condition, with this number anticipated to rise to almost 48% by 2050. Therefore, the rise in chronic conditions is driving the pharmaceutical API manufacturing market.

Global Pharmaceutical API Manufacturing Market Major Players

Major companies operating in the pharmaceutical api manufacturing market report are Pfizer Inc, Sanofi S.A, Teva Pharmaceutical Industries Ltd., Aurobindo Pharma, Dr. Reddy’s Laboratories, BASF SE, Sun Pharmaceutical Industries Ltd, Novartis AG, Lupin Ltd, Cipla Inc., Arlak Biotech, Healthkind Labs Pvt. Ltd, SwisscheM Healthcare Pvt. Ltd, Apikos Pharma, Kolaz Biotech, CStone Pharma, CARsgen Therapeutics, JW Therapeutics, BeiGene, Takeda Pharmaceuticals, Astellas Pharma Inc, Otsuka Pharmaceutical Co, Ltd, Legend Biotech Co, Zai Lab, Daiichi Pharmaceutical, Sankyo, GlaxoSmithKline (GSK), AstraZeneca, Abbott Laboratories, Vectura Group, Roche Holding AG, Merck & Co, Boehringer Ingelheim, Zentiva, Microgen, Geropharm, Valenta, NovaMedica, Veropharm, Celon Pharma, SynBio, Generium, Skopinpharm, ALMEDIS, Biocad, Farmacol, Polska Grupa Farmaceutyczna, Polpharma, Mylan, BioVectra, Celgene Corporation, Kashiv Pharma, Cambrex, Eli Lilly and Company, Bristol-Myers Squibb Company, Apotex, Gilead Sciences, AbbVie Inc, Hisun USA Inc, AMEGA Biotech, BioMarin Pharmaceutical, Ferring Pharmaceuticals, Tikun Olam Cannbit, Wavelength Pharmaceuticals, SAUDIBIO, Tabuk Pharmaceuticals, Bayer, Adcock Ingram, Johnson & Johnson, Eurolab, Ranbaxy (SA) (Pty) Ltd, Aspen

Global Pharmaceutical API Manufacturing Market Restraint: Stringent Regulatory Approvals Hinder The Pace Of The Pharmaceutical Api Manufacturing Market

Stringent regulations for the approval of pharmaceutical drugs act as a restraint on the pharmaceutical API manufacturing market. Various regions have their own set of rules, guidelines, and regulations set by their respective drug regulatory bodies. For example, in Japan, the manufacturers have to register an API with Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) through the country’s Drug Master File (DMF) system. Products like APIs and new excipients i.e., inactive substances used in a drug should be registered compulsorily. The API manufacturer is also responsible for DMF registration, even if they don't have an office in Japan. They should appoint an in-country caretaker (ICC) to apply on their behalf. Also, if there are any changes to be made to DMF products, either an application for change in registration or a minor change notification should be submitted by the ICC to the PMDA. This whole process delays the drug approvals, thereby negatively affecting the pharmaceuticals API manufacturing market.

Global Pharmaceutical API Manufacturing Market Trend: Technological Advancements Streamlining The Api Manufacturing Process

Many companies use modern technologies such as process control, and powder handling to optimize API manufacturing. These technologies include advances in Lyophilization i.e., freeze-drying process. It is a low-temperature dehydration process that involves freezing the product, lowering pressure, and then removing the ice formed. For instance, Telstar, a company that manufactures efficient integrated systems for pharmaceutical and manufacturing processes, developed LyoGistics Zero, an automatic loading and unloading system for freeze dryers to manufacture hazardous products. The system uses a linear magnetic driving mechanism that functions without racks and belts to reduce particle generation and this improves the hygiene in API manufacturing. Also, ILC Dover, a pharmaceutical company, developed the JetBreaker system, a semi-automatic powder handling system that separates powdered media and buffers powders so that they can be mixed better in a solution.

Global Pharmaceutical API Manufacturing Market Trend: Pharmaceutical Api Manufacturing Companies Innovate With Solubility Solutions Like Apisolex To Enhance Manufacturing Efficiency And Api Solubility

Major companies operating in the pharmaceutical API manufacturing market are focused on developing innovative solutions such as the Apisolex to streamline manufacturing and minimize API loss. Apisolex is a novel solubility-enhancing excipient technology that addresses and overcomes solubility challenges. For instance, in March 2022, Lubrizol Life Science (LLS) Health, a US-based pharmaceutical contract development and drug product manufacturing organization launched Apisolex, an innovative solubility-enhancing excipient developed to enhance solubility and simplify the manufacturing of parenteral drug products. It can amplify solubility up to 50,000-fold, support high drug loading, and optimize manufacturing by reducing API loss and ensuring efficient encapsulation.

Pharmaceutical API Manufacturing Market Merger And Acquisition: Piramal Pharma Ltd Strategic Acquisition Of Hemmo Pharmaceuticals

In March 2021, Piramal Pharma Ltd., an India-based healthcare solutions company, acquired Hemmo Pharmaceuticals for an amount of $105.8 million. This acquisition is expected to expand PPS’s capacity to provide integrated services to its clients globally by gaining access to the expanding peptide API industry. The deal would also increase peptide API manufacturing and development capabilities. Hemmo Pharmaceuticals is an India-based developer and manufacturer of peptide APIs.

Regional Analysis For The Global Pharmaceutical API Manufacturing Market

North America was the largest region in the pharmaceutical API manufacturing market in 2023. The Middle East is expected to be the fastest-growing region in the global pharmaceutical API manufacturing market share during the forecast period. The regions covered in the pharmaceutical api manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pharmaceutical api manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The pharmaceutical active pharmaceutical ingredients (API) manufacturing market includes tablets, capsules, creams, and injectable sales. Values in this market are factory gate values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The pharmaceutical active pharmaceutical ingredients (API) manufacturing market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical active pharmaceutical ingredients (API) manufacturing market statistics, including pharmaceutical active pharmaceutical ingredients (API) manufacturing industry global market size, regional shares, competitors with a pharmaceutical active pharmaceutical ingredient (API) manufacturing market share, detailed pharmaceutical active pharmaceutical ingredients (API) manufacturing market segments, pharmaceutical active pharmaceutical ingredients (API) manufacturing market trends and opportunities, and any further data you may need to thrive in the pharmaceutical active pharmaceutical ingredients (API) manufacturing industry. The pharmaceutical active pharmaceutical ingredients (API) manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Pharmaceutical API Manufacturing Report Forecast And Analysis
Report AttributeDetails
Market Size Value In 2024 $219.76 billion
Revenue Forecast In 2033 $279.03 billion
Growth Rate CAGR of 6.2% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Therapy Area: Cardiovascular Disorders, Metabolic Disorders, Neurological Disorders, Oncology, Musculoskeletal Disorders, Other Therapeutics Uses
2) By API Type: Chemical API, Biological API
3) By Drug Type: Prescription Drugs, Over-The-Counter (OTC) Drugs
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc; Sanofi S.A; Teva Pharmaceutical Industries Ltd.; Aurobindo Pharma; Dr. Reddy’s Laboratories; BASF SE; Sun Pharmaceutical Industries Ltd; Novartis AG; Lupin Ltd; Cipla Inc.; Arlak Biotech; Healthkind Labs Pvt. Ltd; SwisscheM Healthcare Pvt. Ltd; Apikos Pharma; Kolaz Biotech; CStone Pharma; CARsgen Therapeutics; JW Therapeutics; BeiGene; Takeda Pharmaceuticals; Astellas Pharma Inc; Otsuka Pharmaceutical Co, Ltd; Legend Biotech Co; Zai Lab; Daiichi Pharmaceutical; Sankyo; GlaxoSmithKline (GSK); AstraZeneca; Abbott Laboratories; Vectura Group; Roche Holding AG; Merck & Co; Boehringer Ingelheim; Zentiva; Microgen; Geropharm; Valenta; NovaMedica; Veropharm; Celon Pharma; SynBio; Generium; Skopinpharm; ALMEDIS; Biocad; Farmacol; Polska Grupa Farmaceutyczna; Polpharma; Mylan; BioVectra; Celgene Corporation; Kashiv Pharma; Cambrex; Eli Lilly and Company; Bristol-Myers Squibb Company; Apotex; Gilead Sciences; AbbVie Inc; Hisun USA Inc; AMEGA Biotech; BioMarin Pharmaceutical; Ferring Pharmaceuticals; Tikun Olam Cannbit; Wavelength Pharmaceuticals; SAUDIBIO; Tabuk Pharmaceuticals; Bayer; Adcock Ingram; Johnson & Johnson; Eurolab; Ranbaxy (SA) (Pty) Ltd; Aspen
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Pharmaceutical API Manufacturing Market Characteristics

    3. Pharmaceutical API Manufacturing Market Trends And Strategies

    4. Pharmaceutical API Manufacturing Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Pharmaceutical API Manufacturing Market Size and Growth

    5.1. Global Pharmaceutical API Manufacturing Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Pharmaceutical API Manufacturing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Pharmaceutical API Manufacturing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Pharmaceutical API Manufacturing Market Segmentation

    6.1. Global Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Cardiovascular disorders

    Metabolic disorders

    Neurological disorders

    Oncology

    Musculoskeletal disorders

    NSAIDs

    Other therapeutics uses

    6.2. Global Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Chemical API

    Biological API

    6.3. Global Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Prescription Drugs

    Over-the-counter (OTC) Drugs

    7. Pharmaceutical API Manufacturing Market Regional And Country Analysis

    7.1. Global Pharmaceutical API Manufacturing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Pharmaceutical API Manufacturing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Pharmaceutical API Manufacturing Market

    8.1. Asia-Pacific Pharmaceutical API Manufacturing Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Pharmaceutical API Manufacturing Market

    9.1. China Pharmaceutical API Manufacturing Market Overview

    9.2. China Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Pharmaceutical API Manufacturing Market

    10.1. India Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Pharmaceutical API Manufacturing Market

    11.1. Japan Pharmaceutical API Manufacturing Market Overview

    11.2. Japan Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Pharmaceutical API Manufacturing Market

    12.1. Australia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Pharmaceutical API Manufacturing Market

    13.1. Indonesia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Pharmaceutical API Manufacturing Market

    14.1. South Korea Pharmaceutical API Manufacturing Market Overview

    14.2. South Korea Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Pharmaceutical API Manufacturing Market

    15.1. Western Europe Pharmaceutical API Manufacturing Market Overview

    15.2. Western Europe Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Pharmaceutical API Manufacturing Market

    16.1. UK Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Pharmaceutical API Manufacturing Market

    17.1. Germany Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Pharmaceutical API Manufacturing Market

    18.1. France Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Pharmaceutical API Manufacturing Market

    19.1. Italy Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Pharmaceutical API Manufacturing Market

    20.1. Spain Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Pharmaceutical API Manufacturing Market

    21.1. Eastern Europe Pharmaceutical API Manufacturing Market Overview

    21.2. Eastern Europe Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Pharmaceutical API Manufacturing Market

    22.1. Russia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Pharmaceutical API Manufacturing Market

    23.1. North America Pharmaceutical API Manufacturing Market Overview

    23.2. North America Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Pharmaceutical API Manufacturing Market

    24.1. USA Pharmaceutical API Manufacturing Market Overview

    24.2. USA Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Pharmaceutical API Manufacturing Market

    25.1. Canada Pharmaceutical API Manufacturing Market Overview

    25.2. Canada Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Pharmaceutical API Manufacturing Market

    26.1. South America Pharmaceutical API Manufacturing Market Overview

    26.2. South America Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Pharmaceutical API Manufacturing Market

    27.1. Brazil Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Pharmaceutical API Manufacturing Market

    28.1. Middle East Pharmaceutical API Manufacturing Market Overview

    28.2. Middle East Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Pharmaceutical API Manufacturing Market

    29.1. Africa Pharmaceutical API Manufacturing Market Overview

    29.2. Africa Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Pharmaceutical API Manufacturing Market Competitive Landscape And Company Profiles

    30.1. Pharmaceutical API Manufacturing Market Competitive Landscape

    30.2. Pharmaceutical API Manufacturing Market Company Profiles

    30.2.1. Pfizer Inc

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Sanofi S.A

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Teva Pharmaceutical Industries Ltd.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Aurobindo Pharma

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Dr. Reddy’s Laboratories

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Pharmaceutical API Manufacturing Market Other Major And Innovative Companies

    31.1. BASF SE

    31.2. Sun Pharmaceutical Industries Ltd

    31.3. Novartis AG

    31.4. Lupin Ltd

    31.5. Cipla Inc.

    31.6. Arlak Biotech

    31.7. Healthkind Labs Pvt. Ltd

    31.8. SwisscheM Healthcare Pvt. Ltd

    31.9. Apikos Pharma

    31.10. Kolaz Biotech

    31.11. CStone Pharma

    31.12. CARsgen Therapeutics

    31.13. JW Therapeutics

    31.14. BeiGene

    31.15. Takeda Pharmaceuticals

    32. Global Pharmaceutical API Manufacturing Market Competitive Benchmarking

    33. Global Pharmaceutical API Manufacturing Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Pharmaceutical API Manufacturing Market

    35. Pharmaceutical API Manufacturing Market Future Outlook and Potential Analysis

    35.1 Pharmaceutical API Manufacturing Market In 2028 - Countries Offering Most New Opportunities

    35.2 Pharmaceutical API Manufacturing Market In 2028 - Segments Offering Most New Opportunities

    35.3 Pharmaceutical API Manufacturing Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Pharmaceutical API Manufacturing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Pharmaceutical API Manufacturing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Pfizer Inc Financial Performance
  • Table 75: Sanofi S.A Financial Performance
  • Table 76: Teva Pharmaceutical Industries Ltd. Financial Performance
  • Table 77: Aurobindo Pharma Financial Performance
  • Table 78: Dr. Reddy’s Laboratories Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Pharmaceutical API Manufacturing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Pharmaceutical API Manufacturing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Pfizer Inc Financial Performance
  • Figure 75: Sanofi S.A Financial Performance
  • Figure 76: Teva Pharmaceutical Industries Ltd. Financial Performance
  • Figure 77: Aurobindo Pharma Financial Performance
  • Figure 78: Dr. Reddy’s Laboratories Financial Performance

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Read More

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

Read More

The Microbiome Market Share, Market Size, And Growth Rate 2022

Read More

Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the nucleic acid based gene therapy market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the radiopharmaceuticals market research report 2022 with industry size, share, segments and market growth

Read More

Pharmaceutical Packaging Equipment Global Market Report 2024 – By Product (Primary Packaging Equipment, Secondary Packaging Equipment, Labelling And Sterilization Equipment), By Packaging Type (Liquids Packaging Equipment, Solid Packaging Equipment, Semi-Solid Packaging Equipment), By Equipment Type (Blenders, Granulators, Tablet Pressers, Tablet Coating Machine, Allied Machines), By Mode of Administration (Injectable Administration, Topical Administration, Oral Administration) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Pharmaceutical Processing Seals Global Market Report 2024 – By Type (O-rings, Gaskets, Lip seals, D seals, Other types (Diaphragms and X-rings)), By Material (Metals, PTFE, Silicone, Nitrile Rubber, EPDM, Other materials), By Application (Manufacturing Equipment, Agitators, Mixers, Reactors, Gear Boxes, Other applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Psychedelic Drugs Global Market Report 2024 – By Type (Lysergic Acid Diethylamide (LSD), Ketamine, Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Salvia), By Disease Indication (Depression, PTSD), By Origin (Natural, Synthetic), By Application (Treatment-Resistant Depression, Opiate addiction, Post- Traumatic Stress Disorder, Narcolepsy, Panic Disorders), By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Aerospace Valves Global Market Report 2024 – By Type (Butterfly Valves, Rotary Valves, Solenoid Valves, Flapper-nozzle Valves, Poppet Valves, Gate Valves, Ball Valves, Other Types), By Material (Stainless Steel, Titanium, Aluminum, Other Materials), By Application (Fuel System, Hydraulic System, Environmental Control System, Pneumatic System, Lubrication System, Water & Wastewater System), By End Use (OEM, Aftermarket) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Healthcare Mobility Solutions Global Market Report 2024 – By Product type (Mobile Devices, Mobile Applications, Enterprise mobility platforms, Other Product Types), By Applications (Enterprise Solutions, mHealth Applications, Other Applications), By End User (Payers, Providers, Hospitals, Laboratories, Patients, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Pharmaceutical Sterility Testing Global Market Report 2024 – By Sample (Sterile Drugs, Medical Devices, Biologics and Therapeutics), By Product Type (Instruments, Kits and Reagents, Services), By Type (In- house, Outsourcing), By Test Type (Sterility Testing, Bioburden Testing, Bacterial Endotoxin Testing), By End- User (Compounding Pharmacies, Medical Devices Companies, Pharmaceutical Companies) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Pharmaceutical Drugs Global Market Report 2024 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorder Drugs, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Respiratory Disease Drugs, Vaccine And Therapeutic Nutrients, Minerals), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Other Distribution Channels), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Over-The-Counter (OTC) Drugs, Prescription-Based Drugs) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Pharmaceutical Excipients Global Market Report 2024 – By Product (Inorganic Chemicals, Organic Chemicals, Other Products), By Functionality (Fillers And Diluents, Suspending And Viscosity Agents, Coating Agents, Binders, Flavoring Agents And Sweeteners, Disintegrants, Colorants, Lubricants And Glidants, Other Functionalities), By Type Of Formulation (Oral Formulation, Topical Formulation, Parenteral Formulation, Other Formulations) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the pharmaceutical API manufacturing market?

Pharmaceutical active pharmaceutical ingredients (API) manufacturing refers to the production of the active substances that give a pharmaceutical medicine its desired impact on the body to treat a condition. Chemical components must be processed in order to make APIs. A biological drug's active component is referred to as a bulk process intermediate. For further insights on the pharmaceutical API manufacturing market, request a sample here

How will the pharmaceutical API manufacturing market drivers and restraints affect the pharmaceutical API manufacturing market dynamics? What forces will shape the pharmaceutical API manufacturing industry going forward?

The pharmaceutical API manufacturing market major growth driver - Rising Aging Population Fueling Growth In Pharmaceutical Api Manufacturing. For further insights on the pharmaceutical API manufacturing market, request a sample here

What is the forecast market size or the forecast market value of the pharmaceutical API manufacturing market?

The pharmaceutical API manufacturing market size has grown strongly in recent years. It will grow from $206.95 billion in 2023 to $219.76 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to increase in pharmaceutical r&d expenditure, increasing preference for outsourcing apis, growing prevalence of chronic illness, increased healthcare expenditure, a rise in disposable income, an increase in patent expiration and growing government policies for api production. . The pharmaceutical API manufacturing market size is expected to see strong growth in the next few years. It will grow to $279.03 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to a rise in ageing population, rapid technological advancements, rising prevalence of cancer, increasing mergers and acquisitions and high potential of emerging economies will drive the growth.. Major trends in the forecast period include focus on production facility expansion, use of artificial intelligence (ai), focus on greener api manufacturing, increasing investments and focus on use of qr code labelling. . For further insights on the pharmaceutical API manufacturing market, request a sample here

How is the pharmaceutical API manufacturing market segmented?

The pharmaceutical API manufacturing market is segmented
1) By Therapy Area: Cardiovascular Disorders, Metabolic Disorders, Neurological Disorders, Oncology, Musculoskeletal Disorders, Other Therapeutics Uses
2) By API Type: Chemical API, Biological API
3) By Drug Type: Prescription Drugs, Over-The-Counter (OTC) DrugsFor further insights on the pharmaceutical API manufacturing market, request a sample here

Which region has the largest share of the pharmaceutical API manufacturing market? What are the other regions covered in the report?

North America was the largest region in the pharmaceutical API manufacturing market in 2023. The Middle East is expected to be the fastest-growing region in the global pharmaceutical API manufacturing market share during the forecast period. The regions covered in the pharmaceutical API manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the pharmaceutical API manufacturing market, request a sample here.

Who are the major players in the pharmaceutical API manufacturing market?

Major companies operating in the pharmaceutical API manufacturing market report are Pfizer Inc, Sanofi S.A, Teva Pharmaceutical Industries Ltd., Aurobindo Pharma, Dr. Reddy’s Laboratories, BASF SE, Sun Pharmaceutical Industries Ltd, Novartis AG, Lupin Ltd, Cipla Inc., Arlak Biotech, Healthkind Labs Pvt. Ltd, SwisscheM Healthcare Pvt. Ltd, Apikos Pharma, Kolaz Biotech, CStone Pharma, CARsgen Therapeutics, JW Therapeutics, BeiGene, Takeda Pharmaceuticals, Astellas Pharma Inc, Otsuka Pharmaceutical Co, Ltd, Legend Biotech Co, Zai Lab, Daiichi Pharmaceutical, Sankyo, GlaxoSmithKline (GSK), AstraZeneca, Abbott Laboratories, Vectura Group, Roche Holding AG, Merck & Co, Boehringer Ingelheim, Zentiva, Microgen, Geropharm, Valenta, NovaMedica, Veropharm, Celon Pharma, SynBio, Generium, Skopinpharm, ALMEDIS, Biocad, Farmacol, Polska Grupa Farmaceutyczna, Polpharma, Mylan, BioVectra, Celgene Corporation, Kashiv Pharma, Cambrex, Eli Lilly and Company, Bristol-Myers Squibb Company, Apotex, Gilead Sciences, AbbVie Inc, Hisun USA Inc, AMEGA Biotech, BioMarin Pharmaceutical, Ferring Pharmaceuticals, Tikun Olam Cannbit, Wavelength Pharmaceuticals, SAUDIBIO, Tabuk Pharmaceuticals, Bayer, Adcock Ingram, Johnson & Johnson, Eurolab, Ranbaxy (SA) (Pty) Ltd, Aspen For further insights on the pharmaceutical API manufacturing market, request a sample here.

What are the key trends in the pharmaceutical API manufacturing market?

Major trend in the pharmaceutical API manufacturing market - Technological Advancements Streamlining The Api Manufacturing Process. For further insights on the pharmaceutical API manufacturing market, request a sample here.

What are the major opportunities in the pharmaceutical API manufacturing market? What are the strategies for the pharmaceutical API manufacturing market?

For detailed insights on the major opportunities and strategies in the pharmaceutical API manufacturing market, request a sample here.

How does the pharmaceutical API manufacturing market relate to the overall economy and other similar markets?

For detailed insights on pharmaceutical API manufacturing market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the pharmaceutical API manufacturing industry?

For detailed insights on the mergers and acquisitions in the pharmaceutical API manufacturing industry, request a sample here.

What are the key dynamics influencing the pharmaceutical API manufacturing market growth? SWOT analysis of the pharmaceutical API manufacturing market.

For detailed insights on the key dynamics influencing the pharmaceutical API manufacturing market growth and SWOT analysis of the pharmaceutical API manufacturing industry, request a sample here.